Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Esmolol on ONSD/ETD Ratio During Intubation for Cerebral Aneurysm Coil Embolization
NCT07660861Not yet recruiting
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised trial of remifentanil (2 arms), sponsored by Fatih Sultan Mehmet Training and Research Hospital. Primary endpoint: Change in Optic Nerve Sheath Diameter/Eyeball Transverse Diameter Ratio at 5 minutes. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT07660861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07660861.